Yonghe Medical Group Co Ltd
Yonghe Medical Group Co Ltd operates in the healthcare facilities and services industry, providing pharmaceutical and medical services to patients and healthcare institutions.
Business. Yonghe Medical Group Co Ltd (2279.HK) is a healthcare services and equipment company primarily engaged in pharmaceutical activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in China, the company is listed on the Hong Kong Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Yonghe Medical Group Co Ltd (2279.HK) is a healthcare services and equipment company primarily engaged in pharmaceutical activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in China, the company is listed on the Hong Kong Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Yonghe Medical Group Co Ltd has a market capitalization of 1.16 billion CNY, with a current market price of 2.2 CNY per share. The company has 525.22 million shares outstanding, with no dilution from preferred or convertible shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
The company's profitability and return metrics are not available in the current dataset, making it difficult to compare with industry_config preferred metrics or cohort medians. Analysts have assigned a mean price target of 2.46 CNY, indicating a potential upside of 11.8% from the current market price. The mean recommendation score of 2.00 suggests a neutral outlook, with one "buy" rating and no "strong buy" or "hold" ratings.
Geographic and segment exposure data are not disclosed in the available source documents, so revenue concentration and segment performance cannot be analyzed. The company's growth trajectory is also unclear, as no revenue history or outlook numeric deltas are provided in the dataset.
The risk assessment indicates a low dilution potential, with no evidence of recent equity issuance or dilutive instruments in the financial snapshot. However, the absence of liquidity metrics and balance-sheet inputs limits the ability to assess credit risk or capital structure stability.
No recent filings, transcripts, or material events are disclosed in the available source documents, so the company's recent operational or strategic developments cannot be evaluated.
- The company has a market capitalization of 1.16 billion CNY and a current market price of 2.2 CNY per share.
- Analysts have assigned a mean price target of 2.46 CNY, suggesting a potential upside of 11.8%.
- No balance-sheet inputs or liquidity metrics are available, limiting the ability to assess financial risk.
- The company has a low dilution potential, with no evidence of recent equity issuance.
- No recent events or strategic developments are disclosed in the available data.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue ¥1.78B, +25,8% YoY; Operating income −229,0% YoY.
- ▍Revenue ¥1.78B, +25,8% YoY
- ▍Operating income −229,0% YoY
- ▍Net income −536,4% YoY
- ▍Free cash flow −159,1% YoY
- ▍Net margin -30.7%
Revenue ¥1.41B, −34,9% YoY; Operating income −163,1% YoY.
- ▍Revenue ¥1.41B, −34,9% YoY
- ▍Operating income −163,1% YoY
- ▍Net income −171,4% YoY
- ▍Free cash flow −343,5% YoY
- ▍Net margin -6.1%
Revenue ¥2.17B; Operating income ¥256.1M.
- ▍Revenue ¥2.17B
- ▍Operating income ¥256.1M
- ▍Net margin 5.5%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Yonghe Medical Group Co Ltd Market data — financials · 2026-05-26
- Yonghe Medical Group Co Ltd Market data — analyst estimates · 2026-05-26